1299 – Cardiometabolic Risks and the Transition to InSTIs in Aging PLWH in South Africa
Background The transition to integrase inhibitors has been associated with weight gain and increases in cardiometabolic risk factors, but evidence for the impact of this transition over longer time horizons in populations with HIV-negative comparators is limited. We evaluated the impact of the switch from efavirenz to dolutegravir (DTG) on weight and a suite of…